Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06612983 · ClinicalTrials.gov registry record · NA
Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait
A NA study, sponsored by Beth Marschner.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06612983: Completed NA study, sponsored by Beth Marschner.
NCT06612983 is a NA study that has completed, run by Beth Marschner. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06612983, a NA study, has completed, sponsored by Beth Marschner.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy tissue of adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the ankle and knee? * Does IASTM treatment have an effect on movement patterns including gait - how a person walks? Researchers will compare pre-test and post-test data from the same individual on their day with treatment to the pre-test and post-test data from the same individual on their day without treatment to see if ROM or gait are effected by use of IASTM. Participants will: * Complete a past medical and injury history questionnaire * Have ankle and knee range of motion (ROM) measurements taken on both lower extremities using a goniometer * Undergo a gait analysis to determine center of gravity, center of pressure, step length, stride length, and stride frequency using Noraxon MyoMuscle Ultium Insoles * Undergo IASTM treatment techniques using the HawkGrips tools including applying emollient to the skin to reduce friction on the surface followed by scanning the gastroc/soleus complexes and Achilles tendons using the HG8-Scanner tool for 15 strokes in each direction to identify areas of concern, then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction. Treatment techniques should last for 10 minutes in total on each side. * Complete the ankle and knee ROM measurements as well as gait analysis again to document progress at the end of the first session. * Return three to seven days after the first session in which the subject will have the walking treatment. * Undergo the same baseline pre-test measurements for range of motion and gait analysis as the first session * Experience the walking treatment by walking for the same time period that the IASTM treatmen
Interventions
- OTHER Instrument Assisted Soft Tissue Mobilization
- OTHER Walking Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06612983
The ClinicalTrials.gov registry entry for NCT06612983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Marschner, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Instrument Assisted Soft Tissue Mobilization is the first listed.
NCT06612983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06612983 about?
NCT06612983 is a clinical study titled "Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait". The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy tissue of adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the ankle and knee? * Does I...
What is the current status of trial NCT06612983?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-01-09. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT06612983?
The interventions under investigation include: Instrument Assisted Soft Tissue Mobilization (OTHER), Walking Treatment (OTHER).
Who is sponsoring clinical trial NCT06612983?
This trial is sponsored by Beth Marschner, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.